This analysis demonstrates improved estimation of risks in insurance claims and housing prices using the generated log exponentiated polynomial family.
This paper introduces a new class of probability distributions, termed the generated log exponentiated polynomial (GLEP) family, designed to enhance flexibility in modeling complex real financial data. The proposed family is constructed through a novel cumulative distribution function that combines logarithmic and exponentiated polynomial structures, allowing for rich distributional shapes and tail behaviors. We present comprehensive mathematical properties, including useful series expansions for the density, cumulative, and quantile functions, which facilitate the derivation of moments, generating functions, and order statistics. Characterization results based on the reverse hazard function and conditional expectations are established. The model parameters are estimated using various frequentist methods, including Maximum Likelihood Estimation (MLE), Cramer–von Mises (CVM), Anderson–Darling (ADE), Right Tail Anderson–Darling (RTADE), and Left Tail Anderson–Darling (LEADE), with a comparative simulation study assessing their performance. Risk analysis is conducted using actuarial key risk indicators (KRIs) such as Value-at-Risk (VaR), Tail Value-at-Risk (TVaR), Tail Variance (TV), Tail Mean Variance (TMV), and excess function (EL), demonstrating the model’s applicability in financial and insurance contexts. The practical utility of the GLEP family is illustrated through applications to real and simulated datasets, including house price dynamics and insurance claim sizes. Peaks Over Random Threshold Value-at-Risk (PORT-VaR) analysis is applied to U.K. motor insurance claims and U.S. house prices datasets. Some recommendations are provided. Finally, a comparative study is presented to prove the superiority of the new family.
No takes yet. Share an insight, caveat, or question.
AboAlkhair et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: